Treatment with BB-94, a broad spectrum inhibitor of zinc-dependent metalloproteinases, causes deviation of the cytokine profile towards Type-2 in experimental pulmonary tuberculosis in Balb/c mice

2017-06-302026-03-272017-06-302000Tomás Martínez Ibarra0959-967310.1046/j.1365-2613.2000.00152.x https://doi.org/10.1046/j.1365-2613.2000.00152.xhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2517727/https://repositorio.inprf.gob.mx/handle/123456789/6814engacceso cerradoMatrix-metalloproteinaseTumor-necrosis-factorFactor AlphaMycobacterium tuberculosisPancreatic-cancerBatimastat BB-94TNF-AlphaExpressionCellPathogenesisTreatment with BB-94, a broad spectrum inhibitor of zinc-dependent metalloproteinases, causes deviation of the cytokine profile towards Type-2 in experimental pulmonary tuberculosis in Balb/c micearticle1365-26133Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, México.199-209Malden81Matrix metalloproteinasesTuberculosisCytokine profileMetaloproteinasas de matrizTuberculosisPerfil de citoquinas